InvestWiser

Dicot AB

DICOTNasdaq StockholmHealthcareMarket value 721 m SEK
0.21SEK −1.8%
last day · Price as of 18 November 2026

The answer first

Does Dicot beat the market?

No, Dicot has not beaten the market over the last year.

Dicot−41.4%Stockholm (OMXSGI)+18.4%
  • The ranking · Quality, value and trend combined

    Better than 28% of Nordic stocks

    • Quality75
    • Value5
    • Trend41

    No. 110 of 195 in healthcare

Max for seven days

Follow Dicot with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Dicot

From today, at a price of 0.21 SEK. Write why you follow Dicot, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Dicot

Your first answer is free, no account needed.

Do you own Dicot, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Dicot and a few more. Free, no card.

Past year against the exchange and Super Stock
Dicot−45.8%Stockholm (OMXSGI)+18.4%Super Stock+45.9%
17 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Dicot has fallen 41.4% over the past year, including dividends.
  • Overall, Dicot ranks better than 28% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 89.9%. The price is 95.4% below its peak now.

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

28

Quality, value and trend together. Better than 28% of Nordic stocks.

No. 110 of 195 in healthcare

Quality75
The company · Fundamentals: the accounts

High A solid company: it earns well on its money and has healthy finances.

No. 71 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity–
  • Asset turnoverSales divided by everything the company owns0.00
  • Return on equityProfit divided by equity−32.7%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value5
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 160 of 197 in healthcareTypical in healthcare: 21Typical in the Nordics: 50

  • P/BPrice divided by equity3.1
  • P/SPrice divided by sales–
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flownegative earnings

The ranking is built on P/E, P/B and P/S.

Trend41
The share price · Technical: the price trend

Medium The share price has moved about like most stocks over the last year.

No. 86 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months+0.5%
  • 6 months+0.5%
  • 9 months−32.9%
  • 12 months−41.4%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−3.9%
3 years, per year
+24.1%
5 years, per year
−15.2%
Year to date
−32.2%
Largest fall, 3 years
−89.9%
From a peak to the bottom
From the peak now
−95.4%
How far the price is from the peak
Volatility, 1 year
71.8%
How much the price swings over a year
Beta, 1 year
0.86
How much the price moves when the market moves

Return with dividends reinvested.

About Dicot

Dicot AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 4 employees.

Dicot Pharma AB (publ) engages in the development of pharmaceutical products in Sweden. It develops LIB-01 that is in Phase 2a clinical trial for the treatment of erectile dysfunction and under medical discovery for treating premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB (publ) in May 2024. Dicot Pharma AB (publ) was incorporated in 2015 and is based in Uppsala, Sweden.

See the full analysis of Dicot.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market